332 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 10:57
319 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 10:27
256 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:58
273 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:28
289 0 Fei Yifei 2016-8-22 publish Last reply on 2016-8-22 09:23
360 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 12:03
308 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
315 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
344 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
368 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
300 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
351 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
369 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
260 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
257 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
277 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
309 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
271 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
310 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
366 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
333 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
242 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
299 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
364 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
285 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
Point rules of this version Post Rebroadcast to the audience